Literature DB >> 11145779

Gamma-hydroxybutyrate overdose and physostigmine: teaching new tricks to an old drug?

D G Caldicott1, M Kuhn.   

Abstract

Gamma-hydroxybutyrate was introduced as an anesthetic agent in the 1960s and is still used in some countries, despite recognized disadvantages. More recently, it has emerged as a popular recreational drug. We report 3 cases of gamma-hydroxybutyrate overdose, the effects of which were reversed by the administration of low-dose intravenous physostigmine. The origins of this regimen and the case for physostigmine as a potential antidote are described.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145779     DOI: 10.1067/mem.2001.111642

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  5 in total

Review 1.  Adverse Effects of Physostigmine.

Authors:  Ann M Arens; Tom Kearney
Journal:  J Med Toxicol       Date:  2019-02-11

Review 2.  [Gamma-hydroxybutyrate--a neurotransmitter, medicine, and drug].

Authors:  G Trendelenburg; A Ströhle
Journal:  Nervenarzt       Date:  2005-07       Impact factor: 1.214

3.  [gamma-Hydroxybutyrate intoxication].

Authors:  N Hahne; W Weinmann; B W Nebel
Journal:  Anaesthesist       Date:  2004-10       Impact factor: 1.041

Review 4.  GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.

Authors:  Francesco P Busardò; Alan W Jones
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

Review 5.  Metabolic Alterations Associated with γ-Hydroxybutyric Acid and the Potential of Metabolites as Biomarkers of Its Exposure.

Authors:  Suryun Jung; Suji Kim; Yujin Seo; Sooyeun Lee
Journal:  Metabolites       Date:  2021-02-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.